What this study is
Background:
The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk.
Objective:
To study and better understand the causes of cancer and to find new ways to prevent it.
Eligibility:
The study will include 200,000 adults who get their health care from a partner health care system, are between 30 and 70 years old at enrollment, and have never had cancer. People remain eligible to join if they have or once had non-melanoma skin cancer, or a condition that may raise cancer risk (such as ductal carcinoma in situ, or DCIS).
Design:
Eligible recruits can sign up for Connect online by creating an account on MyConnect using their email address or phone number. After creating an account, they will complete the informed consent process. All information shared through MyConnect is secure to protect participant privacy. After joining the study, participants will be asked to answer online health surveys a few times a year, donate samples of blood, urine, and saliva every two to three years, and safely share access to their electronic health records with Connect. In the future, participants may donate unused samples that are collected at clinical visits, like tissue, stool, or blood, and may mail in samples collected at home. Participants may also share information from personal health trackers, like wearable devices or apps.
This information will help researchers study the health and behavior patterns that may affect cancer risk.
It takes time to understand the causes of cancer, so Connect will go on for many years. The longer people participate, the more researchers may learn. Participants can leave the study at any time.
Learn more about Connect by visiting cancer.gov/connectstudy.
Study details
- Official title
- Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
- Sponsor
- National Cancer Institute (NCI)
- Conditions
- Cancer · General Research Use
- Enrolling
- 200,000 people
- Starts
- 2021-07-26
- Est. completion
- 2070-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 30 Years – 70 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Due to the minimal risk nature of this protocol, all individuals interested and able to participate in Connect for Cancer Prevention, who meet the eligibility criteria at time of initial study invitation, will be able to participate. In order to be eligible to participate in this study, an individual must meet all of the following criteria:; Patients or members of participating IHCS at the time of enrollment; Age between 30 and 70 years old at study invitation If an individual is determined to be ineligible at the time of enrollment due to age, the individual will be allowed to re-enroll at a later time once the recruit meets the age requirement. This includes recruits that did not meet the original age requirement of 40-65 years of age but now meet the updated age range of 30-70.
You can't join if
- Individuals with a confirmed history of invasive cancer (other than non-melanoma skin cancer)
- Individuals with known cognitive impairment documented in their medical record
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (10)
9 openKaiser Permanente Colorado
Denver, Colorado, United States
RecruitingKaiser Permanente Georgia
Atlanta, Georgia, United States
RecruitingKaiser Permanente Hawaii
Honolulu, Hawaii, United States
RecruitingHenry Ford Health Systems
Detroit, Michigan, United States
RecruitingHealthPartners
Minneapolis, Minnesota, United States
RecruitingKaiser Permanente Northwest
Portland, Oregon, United States
RecruitingSanford Health
Sioux Falls, South Dakota, United States
RecruitingBaylor Scott and White Health
Dallas, Texas, United States
RecruitingMarshfield Clinic Health System
Marshfield, Wisconsin, United States
RecruitingUniversity of Chicago Medical Center
Chicago, Illinois, United States
Active, not recruiting
Study team
Sponsor
National Cancer Institute (NCI)
Study ID 10000034
Principal investigator
Nicolas A Wentzensen, M.D.
National Cancer Institute (NCI)
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.